BR100 Decreased By (-0.23%)
BR30 Decreased By (-0.01%)
KSE100 Decreased By (-0.19%)
KSE30 Decreased By (-0.24%)
AGHA 7.74 Increased By ▲ 0.05 (0.65%)
BECO 5.29 Decreased By ▼ -0.02 (-0.38%)
BML 60.01 Decreased By ▼ -1.22 (-1.99%)
BOP 36.46 Increased By ▲ 0.46 (1.28%)
CNERGY 11.94 Increased By ▲ 0.69 (6.13%)
CSIL 6.17 No Change ▼ 0.00 (0%)
FCCL 57.36 Increased By ▲ 0.48 (0.84%)
FFL 16.58 Increased By ▲ 0.07 (0.42%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.32 Decreased By ▼ -0.10 (-1.35%)
KOSM 6.05 No Change ▼ 0.00 (0%)
LOTCHEM 27.14 Decreased By ▼ -0.06 (-0.22%)
MLCF 102.07 Decreased By ▼ -1.02 (-0.99%)
NBP 206.35 Decreased By ▼ -1.28 (-0.62%)
NCPL 62.62 Increased By ▲ 0.70 (1.13%)
NPL 71.98 Decreased By ▼ -0.20 (-0.28%)
OGDC 319.19 Increased By ▲ 0.70 (0.22%)
PACE 11.38 Increased By ▲ 0.32 (2.89%)
PAEL 43.88 Decreased By ▼ -0.50 (-1.13%)
PIBTL 16.84 Decreased By ▼ -0.06 (-0.36%)
PPL 221.55 Decreased By ▼ -0.93 (-0.42%)
PRL 63.75 Decreased By ▼ -0.06 (-0.09%)
PTC 72.41 Decreased By ▼ -0.75 (-1.03%)
SSGC 27.28 Increased By ▲ 0.03 (0.11%)
TBL 9.86 Decreased By ▼ -0.02 (-0.2%)
TELE 8.62 Decreased By ▼ -0.19 (-2.16%)
TPL 20.68 Increased By ▲ 0.34 (1.67%)
TPLP 14.98 Increased By ▲ 0.01 (0.07%)
TREET 24.10 No Change ▼ 0.00 (0%)
TRG 63.29 Increased By ▲ 0.92 (1.48%)

The New York Post has blocked access to its website from the iPad's Safari Web browser in a bid to drive users of Apple's tablet computer to the newspaper's paid application. An iPad user attempting to reach NYPost.com using Safari is met with a page that says "NYPost.com editorial content is now only accessible on the iPad through the New York Post App."
The New York Post iPad application costs 1.99 dollars to download from Apple's App Store and gives a user an introductory 30-day subscription to the News Corp-owned newspaper. A one-month subscription costs 6.99 dollars.
The ban on access to NYPost.com only applies to users of the iPad's Safari browser. Desktop or laptop computer users can access NYPost.com normally.

Copyright Agence France-Presse, 2011

Comments

Comments are closed for this article.